Conclusion: Overall, eszopiclone and lemborexant had a favorable profile, but eszopiclone might cause substantial adverse events and safety data on lemborexant were inconclusive. Doxepin, seltorexant, and zaleplon were well tolerated, but data on efficacy and other important outcomes were scarce and do not allow firm conclusions. Many licensed drugs (including benzodiazepines, daridorexant, suvorexant, and trazodone) can be effective in the acute treatment of insomnia but are associated with poor tolerability, or information about long-term effects is not available. Melatonin, ramelteon, and non-licensed
PubMed 35843245 ↗Melatonin
The short answer. People are split on Melatonin — 42% of 726 say it helped. It is most often used for sleep: 78% of 915 reports say that improved. It is well studied — 688 meta-analyses on PubMed. The most common complaint is drowsiness.
From 1,370 mentions in total — the rest didn't say how it went and aren't counted.
What Melatonin does, according to users
Of the people who reported each effect, the share who said it got better.
What the research says
Systematic reviews and meta-analyses from PubMed, with their published conclusions.
3+ meta-analyses or systematic reviews and 10+ randomized controlled trials in humans. The grade measures how much human research exists — read the conclusions below for what it found. 688 meta-analyses on PubMed ↗ · 1,128 randomized trials ↗
Conclusion: We found that the treatment with exogenous melatonin has positive effects on sleep quality as assessed by the Pittsburgh Sleep Quality Index (PSQI) in adult. In adults with respiratory diseases, metabolic disorders, primary sleep disorders, not with mental disorders, neurodegenerative diseases and other diseases.
PubMed 33417003 ↗Conclusion: Meta-regression models showed that insomnia status (β = 0.50, p < 0.001) and time between treatment administration and the sleep episode (β = -0.16, p = 0.023) were significant predictors of sleep onset latency, while the time of day (β = -0.086, p < 0.01) was the only significant predictor of total sleep time. Our results suggest that advancing the timing of administration (3 h before the desired bedtime) and increasing the administered dose (4 mg/day), as compared to the exogenous melatonin schedule most used in clinical practice (2 mg 30 min before the desired bedtime), might optimize the e
PubMed 38888087 ↗Conclusion: Our findings suggest that melatonin administration in the critically ill may improve perceived sleep and reduce delirium, without increasing adverse effects. Certainty of evidence was negatively affected by the risk of bias and inconsistency. Future RCTs should focus on identifying optimal dosing, administration timing, improving measurements of sleep outcomes, and target populations.
PubMed 40662882 ↗720 human trials on ClinicalTrials.gov test Melatonin — 361 completed, 86 recruiting now. See all on ClinicalTrials.gov ↗
- Cardioprotective Effect of Melatonin Versus Vitamin D in Breast Cancer Patients Receiving Doxorubicin · Melatonin, Breast Cancer Patients Diagnosed · 2026
- Cronobióticos Naturales · Over 18-year-old, Male · 2026
- Melatonin Supplementation and Exercise Program in Breast Cancer Women · Female Breast Cancer, Older Adults · 2025
Reports to the FDA
Adverse-event reports about supplements containing it, submitted to the US FDA by consumers and doctors.
370 reports name a product containing Melatonin (2004–2026); 129 involved hospitalization or worse. Most often reported:
- Dizziness · 36
- Nausea · 34
- Insomnia · 30
- Dyspnoea · 29
- Diarrhoea · 29
- Headache · 27
A report doesn't prove the supplement caused the problem — many products contain several ingredients, and these counts can't tell you how often it happens. Source: FDA CAERS ↗ · raw reports (openFDA) ↗.
What government agencies say
Official records from US, Canadian and EU regulators, each linked to its source.
10 recalls of products named for Melatonin. Most recent:
- 2022-08-10 · Class II: Acidified/Low Acid dietary supplement with no approved process. record ↗
- 2022-02-16 · Class II: cGMP Deviations record ↗
- 2021-05-12 · Class II: One lot of ALA 300 mg Cap-50 were labeled at Melatonin 3 mg Tab-60. record ↗
Class I = could cause serious harm; Class II = temporary or reversible harm; Class III = unlikely to cause harm. Recalls are of specific products and lots, not of the ingredient itself. All recalls (openFDA) ↗
LiverTox rates Melatonin E — an unlikely cause of liver injury. LiverTox entry ↗
- (Used as a) sleep aid (to help promote sleep).
- Helps increase the total sleep time (aspect of sleep quality) in people suffering from sleep restriction or altered sleep schedule (e.g. shift-work and jet lag).
- Helps (to) prevent and/or reduce the effects of jet lag/minimize jet lag (e.g. daytime fatigue, sleep disturbance) (for people/if travelling by plane easterly across two or more time zones/flying east over two or more time zones).
- Helps (to) speed up/reduce the time it takes to fall asleep (sleep onset latency aspect of sleep quality) in people who fall asleep slowly/with delayed sleep phase disorder.
Required cautions: When using this product avoid taking with alcohol or products that cause drowsiness. When using this product avoid driving or using machinery for 5 hours. Ask a health care practitioner if sleeplessness persists for more than 4 weeks (chronic insomnia).
2 authorised claims, e.g.:
- Melatonin contributes to the alleviation of subjective feelings of jet lag register ↗
- Melatonin contributes to the reduction of time taken to fall asleep register ↗
1 proposed claim was rejected, usually because EFSA found the evidence insufficient (example ↗).
NIH has funded 208 research projects with Melatonin in the title, $119,757,682 in total (1985–2026). NIH RePORTER ↗
Dosage people report
As stated by users — not a recommendation. Follow the label or your doctor.
Reported side effects
How often each side effect came up across all reports.
What users say
First-hand experiences, quoted verbatim. We show one positive and one negative where both exist.
“I have taken it nightly for 19 years. Doses ranging from .1 to 10mg. Right now I take 3mg per night. It helps me sleep.”
“A small dose 0.3mg works for me way better than higher doses.”
“I tried 1mg melatonin and this almost doubled my REM sleep but deep sleep stayed the same.”
“I used to take 50 mg before bedtime but now run out of it and use Dramamine instead. Sleep 8 hours. But with Melatonin dreams are more colourful.”
Melatonin compared
Other options for sleep
Sources
- User reports: 1,370 mentions in public discussions, quoted with a link to each discussion (e.g. this thread ↗).
- PubMed (US National Library of Medicine, NIH): meta-analyses ↗ · randomized trials ↗
- ClinicalTrials.gov (NIH): registered trials ↗
- FDA recalls ↗
- LiverTox (NIH) ↗
- NIH RePORTER ↗
- Health Canada ↗
- EU health-claims register ↗
- US Food and Drug Administration: CAERS adverse-event reports ↗
User data from public discussions; research from PubMed. Information only, not medical advice — talk to a doctor before starting, stopping or combining anything. Data updated October 5, 2026. How we rate